Synthetic Genomic Variant Authentication for Secure Transactions
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Consumers face challenges in managing numerous digital accounts and securely accessing their data, particularly in healthcare, due to the complexity of passwords and the vulnerability of genomic information to unauthorized access.
Innovation Solution
A genome-based security device using synthetic genomic variants, which are computer-generated and synchronized with remote servers, ensures secure transactions by generating unique digital transaction tokens based on the user's genomic data, ensuring the information remains intimately linked to the individual.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If consumers use traditional passwords and keys for accessing digital accounts, then account access is enabled, but security vulnerability increases and management complexity increases
Solution Approach 1:
The patent uses synthetic genomic variants as cryptographic copies that replicate the uniqueness and security properties of actual genomic data without exposing the real data. These synthetic variants serve as secure identifiers and authentication mechanisms, eliminating the need for traditional passwords while maintaining security through cryptographic hashing and encryption of the actual genomic information.
Solution Approach 2:
The patent introduces a genomic data processor as an intermediary system that manages the complex tasks of genomic data processing, synthetic variant generation, and cryptographic operations. This intermediary layer abstracts the complexity from the user, enabling secure account management without requiring consumers to directly handle raw genomic data or manage multiple credentials across different services.
2Adaptability or versatility
If consumers store genomic information on transaction devices, then personalized security is achieved, but the risk of unauthorized access to genomic data increases
Solution Approach 1:
The patent creates synthetic copies of genomic data (synthetic variants) that maintain the personalized security benefits of using actual genomic information while eliminating the direct exposure risk. The synthetic variants are cryptographic representations that can be stored and processed without revealing the underlying genomic sequence, thus personalizing security while reducing unauthorized access risk.
Solution Approach 2:
The patent extracts the essential security and identification functions from raw genomic data by transforming them into synthetic variants. This extraction process separates the useful cryptographic properties from the sensitive biological information, allowing the system to utilize genomic personalization for security while containing the raw data risk through encryption and synthetic representation.
3Adaptability or versatility
If consumers manage multiple digital accounts across different institutions, then comprehensive data access is achieved, but the complexity of managing passwords and authentication increases
Solution Approach 1:
The patent implements a universal authentication system where a single synthetic genomic variant can serve as a cryptographic key across multiple digital accounts and services. The genomic data processor can generate and manage synthetic variants for different institutions and account types, providing universal access while maintaining security through institution-specific cryptographic parameters and encryption schemes.
Data Source
AI summary
Various devices, systems, structures and methods are disclosed related to securely authorizing a transaction by synchronizing digital genomic data with associated synthetic genomic variants. An embodiment of the present invention utilizes digital genomic data associated with an entity, such as a person, who may utilize a genome-based security device to complete a transaction. In one embodiment, a person may use a genome-based security device to communicate with an external device over a wireless or other communication interface, synchronize digital genomic data and an associated synthetic variant received from the external device with digital genomic data and associated synthetic variant stored on the genome-based security device.